Chemokine inhibiting piperazine derivatives and their use to treat myocarditis

Details for Australian Patent Application No. 2004266153 (hide)

Owner Schering Aktiengesellschaft Tokyo Medical and Dental University

Inventors Dole, William P.; Koga, Noritaka; Futamatsu, Hideki; Isobe, Mitsuaki; Suzuki, Jun-Ichi

Agent Davies Collison Cave

Pub. Number AU-A-2004266153

PCT Pub. Number WO2005/018642

Priority 60/497,380 22.08.03 US

Filing date 20 August 2004

Wipo publication date 3 March 2005

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/018642 Priority application(s): WO2005/018642

5 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004266154-Dura substiture and a process for producing the same

2004266151-Inhibitors of cathepsin S